Home / Inspections / 1002432

FDA Inspection 1002432 — Nesher Pharmaceuticals (USA) LLC

Nesher Pharmaceuticals (USA) LLC — FEI 1937079

The FDA completed an inspection of Nesher Pharmaceuticals (USA) LLC on February 3, 2017 in Saint Louis, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 3, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Louis, MO (United States)

Facility

Other inspections at this facility

  • 1151305 (VAI Thu Aug 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1095659 (VAI Fri May 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 925349 (VAI Thu May 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 855762 (NAI Thu Nov 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 811438 (VAI Thu Dec 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

  • Injunction (68) (Fri Mar 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources